Evidence map›Paper›PMID 25685141›Full record

ArticleDementia and geriatric cognitive disorders extra

The Alzheimer's disease cooperative study prevention instrument project: longitudinal outcome of behavioral measures as predictors of cognitive decline.

Sarah Jane Banks, Rema Raman, Feng He, David P Salmon, Steven Ferris, Paul Aisen, Jeffrey Cummings

Registry-linked trialAbstract read
In one paragraph

Article in Dementia and geriatric cognitive disorders extra. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05030285 (Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment), which is not on this map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05030285 nacompletednot on this map

Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment

TypeinterventionalSponsorThe University of QueenslandRan2021 to 2022Enrolled10ConditionsPsychotherapy, Cognitive Impairment, AnxietyArmsCognitive Behavioral Therapy (CBT)
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Mild Behavioral Impairment: A Population-Based Study.The Journal of neuropsychiatry and clinical neurosciences · 2026
    Article
  4. Neuropsychiatric symptoms in Alzheimer's disease: Bridging mechanisms, management, and emerging innovations.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  5. Neuropsychiatric symptom phenotypes for early detection of risk in older adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Alzheimer's Disease Prevention Health Coaching.The journal of prevention of Alzheimer's disease · 2022
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah Jane BanksCleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nev., USA.
Rema RamanUniversity of California, San Diego, Calif., USA.
Feng HeUniversity of California, San Diego, Calif., USA.
David P SalmonUniversity of California, San Diego, Calif., USA.
Steven FerrisNew York University Langone Medical Center, New York, N.Y., USA.
Paul AisenUniversity of California, San Diego, Calif., USA.
Jeffrey CummingsCleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nev., USA.

Funding

RECRUITMENT COREU19AG010483 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FELDMAN, HOWARD · 2013 to 2020
$80.6M
VIRUS-INDUCED BRAIN PATHOLOGYP50AG005131 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GALASKO, DOUGLAS R · 1985 to 2018
$55.4M
PSYCHOSOCIAL COREP30AG008051 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MITTELMAN, MARY SHERMAN · 1990 to 2019
$36.1M
NIA NIH HHS P30 AG008051NIA NIH HHS P50 AG005131NIA NIH HHS U19 AG010483
6 · The paper itself

Abstract

BACKGROUND/

methodsThe Alzheimer's Disease Cooperative Study Prevention Instrument Project is a longitudinal study that recruited 644 cognitively healthy older subjects (aged between 75 and 93 years, 58% women) at baseline and evaluated their cognitive change over 4 years. The study was structured like a clinical trial to anticipate a prevention trial and to determine the performance of novel trial instruments in a longitudinal non-interventional trial framework. Behavioral symptoms were assessed at baseline.

resultsThe existence of participant-reported behavioral symptoms at baseline predicted conversion to Clinical Dementia Rating scale score ≥0.5 over the 4-year period.

conclusionsThe results imply that early anxiety and depression may be harbingers of future cognitive decline, and that patients exhibiting such symptoms, even in the absence of co-occurring cognitive symptoms, should be closely followed over time.

Indexed as

AgingAlzheimer's diseaseAnxietyDepressionMild cognitive impairment

Identifiers

PMID25685141
PMCPMC4307008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.